Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
in The Lancet (2021) reported results from the SURPASS-2 trial that showed tirzepatide to be significantly superior in reducing HbA1c levels and body weight in patients with type 2 diabetes inadequately controlled with metformin, compared to a group treated with insulin glargine
Experiencing mild side effects can be normal, especially during the first few weeks after starting your medication or when your dose is increased
If youre on Medicare, Medicaid, or paying cash, this wont help you
One of the most promising new options is tirzepatide a medication recently approved not only for type 2 diabetes but also for chronic weight management
US$ 25.45
US$ 29.90
US$ 23.68
US$ 25.31
US$ 27.72
US$ 20.10
